Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 35.30
+0.92 (2.68%)
Dec 31, 2025, 12:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 23.58 billion as of December 31, 2025. Its market cap has increased by 866.46% in one year.
Market Cap
23.58B
Enterprise Value
23.73B
Revenue
1.30B
Ranking
n/a
PE Ratio
96.73
Stock Price
35.30
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 23.58B, an increase of 128.67%. That is a compound annual growth rate of 28.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 268.64B |
| Hansoh Pharmaceutical Group Company | 222.66B |
| JD Health International | 181.32B |
| Innovent Biologics | 136.55B |
| WuXi Biologics | 131.44B |
| Sino Biopharmaceutical | 112.44B |
| Akeso | 103.72B |
| CSPC Pharmaceutical Group | 97.98B |